Please assess the completion status of the following clinical trial:

Trial Title: Floseal Treatment for Posterior Epistaxis Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* age greater than 18 years of age~* posterior epistaxis~Exclusion Criteria:~* patients with anterior epistaxis~* known sensitivity to any of the materials of Floseal or the topical medications administered as part of the evaluation and treatment of epistaxis (lidocaine, xylometazoline hydrochloride)~* pregnant or breast feeding woman

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Floseal (Type: EXPERIMENTAL): Received 1 syringe of Floseal for treatment of posterior epistaxis.

Based on this trial design, predict the completion outcome and termination type (if applicable).